美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Onestream Inc

24.77

-0.0400-0.16%

成交量：109.28万

成交额：2,706.99万

市值：43.66亿

市盈率：-14.02

高：25.10

开：25.00

低：24.40

收：24.81

数据加载中...

总览公司新闻公告

Os Therapies Incorporated盘中异动大幅下跌6.01%

Os Therapies Incorporated盘中异动急速上涨5.03%报1.78美元

汽车汽配：6月乘用车零售销量同比加速增长，国产品牌占比达64.2%|兴·研究

Os Therapies Incorporated盘中异动临近收盘快速上涨5.37%报1.66美元

Os Therapies Incorporated盘中异动大幅下挫5.00%

Os Therapies Incorporated盘中异动急速跳水6.84%

Os Therapies Incorporated盘中异动股价大跌5.46%报1.73美元

海外消费周报：多项政策出台支持创新药高质量发展商保创新药目录有望于年内落地

申万宏源研究

Os Therapies Incorporated盘中异动早盘快速拉升5.50%报2.02美元

“闯关”FDA，国产肺癌靶向药物如何敲开美国大门？

21世纪经济报道

Os Therapies Incorporated盘中异动早盘大幅拉升5.43%

Onestream, Inc.盘中异动下午盘股价大涨5.01%

Os Therapies Incorporated盘中异动急速拉升8.14%报1.86美元

Onestream, Inc.盘中异动股价大跌5.00%

艾伯维Bcl-2抑制剂VERONA折戟

CPHI制药在线

艾伯维BCL-2抑制剂拓适应症失利，罗氏帕金森药进Ⅲ期，FXIIa单抗在美上市

医药经济报

Os Therapies Incorporated盘中异动股价大跌5.79%报1.79美元

Os Therapies Incorporated盘中异动股价大跌5.16%报1.75美元

Os Therapies Incorporated盘中异动早盘大幅跳水5.61%报1.85美元

Os Therapies Incorporated盘中异动早盘股价大涨5.69%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/OS/news?region=SGP"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OS\",,,,,undefined,":{"symbol":"OS","market":"US","secType":"STK","nameCN":"Onestream Inc","latestPrice":24.77,"timestamp":1753819200000,"preClose":24.81,"halted":0,"volume":1092803,"delay":0,"floatShares":69818472,"shares":176260091,"eps":-1.766751,"marketStatus":"盘前交易","change":-0.04,"latestTime":"07-30 07:46:13 EDT","open":25,"high":25.1,"low":24.4,"amount":27069878.845953,"amplitude":0.028214,"askPrice":25.49,"askSize":43,"bidPrice":24.51,"bidSize":43,"shortable":3,"etf":0,"ttmEps":-1.766751,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753882200000},"marketStatusCode":1,"adr":0,"listingDate":1721793600000,"exchange":"NASDAQ","adjPreClose":24.77,"postHourTrading":{"tag":"盘后","latestPrice":25.1,"preClose":24.77,"latestTime":"18:16 EDT","volume":119091,"amount":2951343.85,"timestamp":1753827407805},"volumeRatio":1.1372894414190284,"impliedVol":0.6115,"impliedVolPercentile":0.5582},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OS\",,,,,undefined,":{"symbol":"OS","floatShares":69818472,"roa":"-35.83%","roe":"-108.78%","lyrEps":-1.232998,"volumeRatio":1.1372894414190284,"shares":176260091,"dividePrice":0,"high":25.1,"amplitude":0.028214,"preClose":24.81,"low":24.4,"week52Low":16.6942,"pbRate":"10.57","psRate":"8.47","week52High":35.39,"institutionHeld":0,"latestPrice":24.77,"eps":-1.766751,"divideRate":0,"volume":1092803,"delay":0,"ttmEps":-1.766751,"open":25,"prevYearClose":28.52,"prevWeekClose":25.01,"prevMonthClose":28.3,"prevQuarterClose":28.3,"fiveDayClose":25.115,"twentyDayClose":28.3,"sixtyDayClose":22.06,"earningDate":1754496000000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OS\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2554782697","title":"Os Therapies Incorporated盘中异动 大幅下跌6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554782697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554782697?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 00:56","pubTimestamp":1753376179,"startTime":"0","endTime":"0","summary":"北京时间2025年07月25日00时56分，Os Therapies Incorporated股票出现异动，股价大幅跳水6.01%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Plus Therapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Liminatus Pharma, Inc.涨幅较大，Tnf Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.、Purple Biotech Ltd较为活跃，换手率分别为662.59%、365.70%、163.77%，振幅较大的相关个股有Osr Holdings Inc C/Wts 09/02/2028 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Psyence Biomedical Ltd.，振幅分别为55.13%、50.00%、47.44%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725005619971c77ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725005619971c77ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4097","OS","OSTX","BK4139"],"gpt_icon":0},{"id":"2553706257","title":"Os Therapies Incorporated盘中异动 急速上涨5.03%报1.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553706257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553706257?lang=zh_cn&edition=fundamental","pubTime":"2025-07-23 01:02","pubTimestamp":1753203734,"startTime":"0","endTime":"0","summary":"北京时间2025年07月23日01时02分，Os Therapies Incorporated股票出现异动，股价快速拉升5.03%。截至发稿，该股报1.78美元/股，成交量22.2009万股，换手率0.65%，振幅3.08%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为1.59%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723010215a6bb68c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723010215a6bb68c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OSTX","OS","BK4097","BK4139"],"gpt_icon":0},{"id":"2553273694","title":"汽车汽配：6月乘用车零售销量同比加速增长，国产品牌占比达64.2%|兴·研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2553273694","media":"华兴证券","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553273694?lang=zh_cn&edition=fundamental","pubTime":"2025-07-21 16:30","pubTimestamp":1753086650,"startTime":"0","endTime":"0","summary":"6月动力电池装车量同比增长36.0%至58.2GWh，单车平均带电量为54.0KWh，环比增长4.2%。6月国内乘用车厂商的零售/批发/生产数量均创当月历史新高，国产品牌零售市场份额达到64.2%。6月乘用车和新能源车零售销量同比分别增长18.1%/29.8%。2025年上半年累计总体乘用车和新能源车零售销量分别为1,094.8万辆/545.8万辆，分别同比增长11.2%/34.1%。6月乘用车销量数据创当月历史新高，国产品牌销量占比达64.2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721164135a6b78031&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721164135a6b78031&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02020","ANPDY","OS","82020","ADAG","BK4139","BK4097","ORR"],"gpt_icon":0},{"id":"2552317866","title":"Os Therapies Incorporated盘中异动 临近收盘快速上涨5.37%报1.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552317866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552317866?lang=zh_cn&edition=fundamental","pubTime":"2025-07-17 03:47","pubTimestamp":1752695271,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日03时47分，Os Therapies Incorporated股票出现异动，股价快速上涨5.37%。截至发稿，该股报1.66美元/股，成交量26.3095万股，换手率0.87%，振幅5.70%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为1.37%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717034752954531fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717034752954531fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4097","OS","OSTX"],"gpt_icon":0},{"id":"2551800841","title":"Os Therapies Incorporated盘中异动 大幅下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551800841","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551800841?lang=zh_cn&edition=fundamental","pubTime":"2025-07-15 00:43","pubTimestamp":1752511431,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日00时43分，Os Therapies Incorporated股票出现波动，股价大幅下跌5.00%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为0.64%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.、Promis Neurosciences Inc.涨幅较大，Windtree Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.较为活跃，换手率分别为2065.20%、1175.20%、705.77%，振幅较大的相关个股有Promis Neurosciences Inc.、Dare Bioscience, Inc.、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为210.04%、206.36%、183.75%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071500435295425610&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071500435295425610&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OS","BK4139","OSTX","BK4097"],"gpt_icon":0},{"id":"2550520979","title":"Os Therapies Incorporated盘中异动 急速跳水6.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550520979","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550520979?lang=zh_cn&edition=fundamental","pubTime":"2025-07-09 02:55","pubTimestamp":1752000957,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日02时55分，Os Therapies Incorporated股票出现异动，股价快速下挫6.84%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为1.10%。其相关个股中，Zyversa Therapeutics, Inc.、湖岸生物、Seastar Medical Holding Corporation涨幅较大，Zyversa Therapeutics, Inc.、Moleculin Biotech, Inc.、Rallybio Corporation较为活跃，换手率分别为4137.58%、632.66%、349.51%，振幅较大的相关个股有Zyversa Therapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为146.75%、73.81%、70.96%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709025557a69daad5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709025557a69daad5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OSTX","BK4139","BK4097","OS"],"gpt_icon":0},{"id":"2549558629","title":"Os Therapies Incorporated盘中异动 股价大跌5.46%报1.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549558629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549558629?lang=zh_cn&edition=fundamental","pubTime":"2025-07-07 21:44","pubTimestamp":1751895870,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时44分，Os Therapies Incorporated股票出现波动，股价快速跳水5.46%。截至发稿，该股报1.73美元/股，成交量19.0751万股，换手率0.63%，振幅4.37%。Os Therapies Incorporated股票所在的生物技术行业中，整体跌幅为0.60%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507072144309539a04d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507072144309539a04d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OS","OSTX","BK4097"],"gpt_icon":0},{"id":"2548836997","title":"海外消费周报：多项政策出台支持创新药高质量发展 商保创新药目录有望于年内落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2548836997","media":"申万宏源研究","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548836997?lang=zh_cn&edition=fundamental","pubTime":"2025-07-04 00:00","pubTimestamp":1751558400,"startTime":"0","endTime":"0","summary":"此外，为适应多层次医疗保障体系发展需要，将增设商业健康保险创新药品目录，重点纳入创新程度高、临床价值大、患者获益显著且超出基本医保保障范围的创新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704165124a72e766d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704165124a72e766d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCM","09688","BK4526","BK4588","BK4548","BK4585","BK4531","LU2488822045.USD","01276","600276","ZLAB","RDC","BK4097","00013","OS","BK4139"],"gpt_icon":0},{"id":"2548038547","title":"Os Therapies Incorporated盘中异动 早盘快速拉升5.50%报2.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548038547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548038547?lang=zh_cn&edition=fundamental","pubTime":"2025-07-03 23:27","pubTimestamp":1751556471,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日23时27分，Os Therapies Incorporated股票出现异动，股价大幅拉升5.50%。截至发稿，该股报2.02美元/股，成交量738.564万股，换手率26.29%，振幅8.90%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为0.53%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070323275195356440&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070323275195356440&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4097","OSTX","OS"],"gpt_icon":0},{"id":"2548082944","title":"“闯关”FDA，国产肺癌靶向药物如何敲开美国大门？","url":"https://stock-news.laohu8.com/highlight/detail?id=2548082944","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548082944?lang=zh_cn&edition=fundamental","pubTime":"2025-07-03 12:34","pubTimestamp":1751517293,"startTime":"0","endTime":"0","summary":"2025年初，迪哲医药研发的肺癌靶向药舒沃哲?（舒沃替尼片）向美国FDA递交新药上市申请并获得优先审评资格，这一消息在医药行业引起了广泛关注。就在7月3日，该药正式获得FDA批准上市，用于经治EGFRExon20ins晚期非小细胞肺癌（NSCLC）患者，成为中国首款独立研发在美获批的全球首创（First-in-Class）新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202507033447331049.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202507033447331049.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4195","BK1141","BK1574","BK1576","BK4211","PFS","OS","06978","BK1583","BK1161","BK4097","03347"],"gpt_icon":0},{"id":"2547654018","title":"Os Therapies Incorporated盘中异动 早盘大幅拉升5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547654018","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547654018?lang=zh_cn&edition=fundamental","pubTime":"2025-06-30 21:47","pubTimestamp":1751291265,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时47分，Os Therapies Incorporated股票出现波动，股价快速上涨5.43%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 涨幅较大，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Inmune Bio Inc.较为活跃，换手率分别为2370.48%、140.53%、78.46%，振幅较大的相关个股有Artelo Biosciences, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 、Eyenovia, Inc.，振幅分别为79.51%、34.23%、26.93%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063021474595315558&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063021474595315558&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OSTX","BK4097","BK4139","OS"],"gpt_icon":0},{"id":"2546756989","title":"Onestream, Inc.盘中异动 下午盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546756989","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546756989?lang=zh_cn&edition=fundamental","pubTime":"2025-06-27 02:55","pubTimestamp":1750964127,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日02时55分，Onestream, Inc.股票出现异动，股价急速拉升5.01%。Onestream, Inc.股票所在的软件服务行业中，整体涨幅为0.72%。其相关个股中，Cyngn Inc.、Core Scientific Inc C/Wts 23/01/2027 、Webull Corporation C/Wts 10/04/2029 涨幅较大，Cyngn Inc.、Jet.AI、Urgent.Ly Inc.较为活跃，换手率分别为7237.79%、66.19%、47.49%，振幅较大的相关个股有Cyngn Inc.、Real Messenger Corp C/Wts 19/11/2029、Core Scientific Inc C/Wts 23/01/2027 ，振幅分别为575.25%、67.32%、66.72%。Onestream, Inc.公司简介：OneStream Inc 是一个支持人工智能且可扩展的软件平台，能够在单一平台上统一核心财务功能以及更广泛的运营数据和流程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627025527979041bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627025527979041bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OS","BK4097"],"gpt_icon":0},{"id":"2546924612","title":"Os Therapies Incorporated盘中异动 急速拉升8.14%报1.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546924612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546924612?lang=zh_cn&edition=fundamental","pubTime":"2025-06-25 21:41","pubTimestamp":1750858902,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日21时41分，Os Therapies Incorporated股票出现异动，股价急速上涨8.14%。截至发稿，该股报1.86美元/股，成交量2.6538万股，换手率0.09%，振幅2.04%。Os Therapies Incorporated股票所在的生物技术行业中，整体跌幅为0.60%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625214142a4bd7354&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625214142a4bd7354&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OS","OSTX","BK4097"],"gpt_icon":0},{"id":"2545449870","title":"Onestream, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545449870","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545449870?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 00:33","pubTimestamp":1750696433,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日00时33分，Onestream, Inc.股票出现波动，股价快速跳水5.00%。截至发稿，该股报26.39美元/股，成交量56.7111万股，换手率0.32%，振幅5.40%。Onestream, Inc.股票所在的软件服务行业中，整体涨幅为0.36%。其相关个股中，Currenc Group Inc.、Alpha Modus Holdings, Inc.、移动财经涨幅较大，Currenc Group Inc.、Wag!Onestream, Inc.公司简介：OneStream Inc 是一个支持人工智能且可扩展的软件平台，能够在单一平台上统一核心财务功能以及更广泛的运营数据和流程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624003353a4b987dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624003353a4b987dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OS","BK4097"],"gpt_icon":0},{"id":"2544166696","title":"艾伯维Bcl-2抑制剂VERONA折戟","url":"https://stock-news.laohu8.com/highlight/detail?id=2544166696","media":"CPHI制药在线","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544166696?lang=zh_cn&edition=fundamental","pubTime":"2025-06-19 18:15","pubTimestamp":1750328104,"startTime":"0","endTime":"0","summary":"关注并星标CPHI制药在线Bcl-2抑制剂“水土不服”2025年6月16日，艾伯维宣布Bcl-2抑制剂维奈克拉联合阿扎胞苷一线治疗高危骨髓增生异常综合征的三期临床VERONA宣告失败。这种异质性导致不同患者对Bcl-2抑制剂的敏感性不同，使得药物难以对所有患者都产生理想疗效。Bcl-2抑制剂作用于白血病细胞的凋亡通路，但骨髓基质细胞的保护作用削弱了其疗效，使得白血病细胞难以被有效清除。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619190433a4b27962&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619190433a4b27962&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4161","LU1057294990.SGD","SG9999011175.SGD","LU2087621335.USD","SG9999015945.SGD","LU2129689514.USD","LU2129689431.USD","LU1929549753.HKD","LU0965509283.SGD","IE00B19Z3B42.SGD","LU0234570918.USD","LU0965509101.SGD","LU0203345920.USD","LU0128525929.USD","LU1003077747.HKD","LU0320765646.SGD","LU1074936037.SGD","OS","LU2089283258.USD","BK4550","LU1989772923.USD","LU0310799852.SGD","IE00BDGV0183.EUR","LU0949170772.SGD","ORR","ABBV","LU1244550221.USD","LU1732800096.USD","IE00BGHQF631.EUR","IE00B19Z3581.USD","LU1989771016.USD","LU1244550577.SGD","LU0158827948.USD","LU1934455863.HKD","LU0456855351.SGD","IE00BFTCPJ56.SGD","LU2468319806.SGD","LU0689472784.USD","BK4585","SG9999003800.SGD","TLS","LU1267930573.SGD","CR","BK4581","LU0211327993.USD","LU1496350171.SGD","LU0417517546.SGD","IE00BVYPNV92.GBP","HR"],"gpt_icon":0},{"id":"2544191987","title":"艾伯维BCL-2抑制剂拓适应症失利，罗氏帕金森药进Ⅲ期，FXIIa单抗在美上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2544191987","media":"医药经济报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544191987?lang=zh_cn&edition=fundamental","pubTime":"2025-06-18 07:05","pubTimestamp":1750201511,"startTime":"0","endTime":"0","summary":"1.艾伯维/基因泰克BCL-2抑制剂拓适应症暂折戟6月16日，基因泰克与艾伯维宣布，BCL-2抑制剂Venclexta联合阿扎胞苷初治高危骨髓增生异常综合征患者的Ⅲ期VERONA研究临床试验未达总生存期这一主要终点。该药已在今年2月在欧盟获批上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618071318a70f3832&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618071318a70f3832&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4533","LU2237443622.USD","LU0456855351.SGD","LU1934455863.HKD","SG9999015986.USD","LU2237443549.SGD","IE0004445239.USD","IE0002141913.USD","LU0943347566.SGD","LU1244550221.USD","LU2129689605.HKD","LU0820561909.HKD","LU2089284900.SGD","IE0002270589.USD","LU0122379950.USD","LU0211327993.USD","LU0158827948.USD","BK4585","IE00BGHQF631.EUR","LU0256863902.USD","LU0553294199.USD","IE00BJT1NW94.SGD","ABBV","LU1551013342.USD","LU2237443382.USD","LU2023251221.USD","IE00BLDYK493.USD","SG9999011175.SGD","LU0965509101.SGD","HAE","LU0912757837.SGD","LU0738911758.USD","LU2347655156.SGD","LU0203345920.USD","OS","LU1551013425.SGD","LU0820561818.USD","IE00B19Z3B42.SGD","LU1934455277.USD","LU1732799900.SGD","LU1169589451.USD","LU1023059063.AUD","LU1929549753.HKD","LU0205193047.USD","LU1989771016.USD","BK4550","LU1585245621.USD","LU0234570918.USD","LU1989772923.USD","LU0985320562.USD"],"gpt_icon":0},{"id":"2544373918","title":"Os Therapies Incorporated盘中异动 股价大跌5.79%报1.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544373918","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544373918?lang=zh_cn&edition=fundamental","pubTime":"2025-06-18 04:15","pubTimestamp":1750191335,"startTime":"0","endTime":"0","summary":"北京时间2025年06月18日04时15分，Os Therapies Incorporated股票出现波动，股价快速下挫5.79%。截至发稿，该股报1.79美元/股，成交量22.2987万股，换手率0.79%，振幅6.32%。Os Therapies Incorporated股票所在的生物技术行业中，整体跌幅为1.71%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506180415359520a2de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506180415359520a2de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OS","BK4139","OSTX","BK4097"],"gpt_icon":0},{"id":"2543263323","title":"Os Therapies Incorporated盘中异动 股价大跌5.16%报1.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543263323","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543263323?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 22:40","pubTimestamp":1749825650,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日22时40分，Os Therapies Incorporated股票出现异动，股价快速跳水5.16%。截至发稿，该股报1.75美元/股，成交量8.7732万股，换手率0.31%，振幅6.52%。Os Therapies Incorporated股票所在的生物技术行业中，整体跌幅为0.49%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613224050977e5aa7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613224050977e5aa7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OS","BK4097","BK4139","OSTX"],"gpt_icon":0},{"id":"2542384995","title":"Os Therapies Incorporated盘中异动 早盘大幅跳水5.61%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542384995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542384995?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 21:57","pubTimestamp":1749650258,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日21时57分，Os Therapies Incorporated股票出现波动，股价急速下跌5.61%。截至发稿，该股报1.85美元/股，成交量5.4093万股，换手率0.19%，振幅3.57%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为0.14%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506112157389517efa9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506112157389517efa9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4097","OS","OSTX"],"gpt_icon":0},{"id":"2542333711","title":"Os Therapies Incorporated盘中异动 早盘股价大涨5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542333711","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542333711?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 22:09","pubTimestamp":1749478199,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日22时09分，Os Therapies Incorporated股票出现波动，股价急速拉升5.69%。截至发稿，该股报1.77美元/股，成交量5.4583万股，换手率0.19%，振幅3.05%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为0.48%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609220959a700ba69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609220959a700ba69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OS","BK4139","OSTX","BK4097"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":83,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OS\",params:#limit:5,,,undefined,":[{"date":"2025-08-07","symbol":"OS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/06","expectedEps":0.01,"defaultRemindTime":1754596800000,"name":null,"time":"盘后","dateTimestamp":1754539200000,"actualEps":null},{"market":"US","date":"2025-05-08","symbol":"OS","fiscalQuarterEnding":"2025/03","expectedEps":-0.03,"name":null,"time":"盘后","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":0.04},{"market":"US","date":"2025-02-11","symbol":"OS","fiscalQuarterEnding":"2024/12","expectedEps":0.02,"name":null,"time":"盘后","type":"earning","dateTimestamp":1739250000000,"reportTimeType":"post","actualEps":0.07},{"market":"US","date":"2024-11-07","symbol":"OS","fiscalQuarterEnding":"2024/09","expectedEps":0,"name":null,"time":"盘后","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-1.06},{"market":"US","date":"2024-09-03","symbol":"OS","fiscalQuarterEnding":"2024/06","expectedEps":-0.11,"name":null,"time":"盘后","type":"earning","dateTimestamp":1725336000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.5714,"hold":0.0952,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":21,"updateTime":1753329600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OS","date":"2025-07-29","current":-18.588158,"percent":0.832653,"low":-1655.61542,"twenty":-430.001496,"median":-26.065361,"eighty":-18.752986,"high":-14.493656,"avg":-324.306428,"sd":560.783679,"marketCap":4373012857},"quantilePoints":[{"date":"2024-08-02","current":-402.058638,"twenty":-402.058638,"median":-402.058638,"eighty":-402.058638,"marketCap":4348264172},{"date":"2024-08-09","current":-394.529993,"twenty":-398.004752,"median":-394.602383,"eighty":-391.489578,"marketCap":4266841869},{"date":"2024-08-16","current":-420.156344,"twenty":-402.058638,"median":-395.977809,"eighty":-394.529993,"marketCap":4543990864},{"date":"2024-08-23","current":-418.563746,"twenty":-420.156344,"median":-400.248867,"eighty":-394.674774,"marketCap":4526766915},{"date":"2024-08-30","current":-439.701867,"twenty":-427.829772,"median":-415.668113,"eighty":-395.977809,"marketCap":4755375690},{"date":"2024-09-06","current":-1412.285699,"twenty":-434.093948,"median":-420.156344,"eighty":-395.977809,"marketCap":4652069092},{"date":"2024-09-13","current":-1421.532228,"twenty":-630.517125,"median":-426.381956,"eighty":-397.599363,"marketCap":4682527160},{"date":"2024-09-20","current":-1491.611188,"twenty":-1406.835113,"median":-428.55368,"eighty":-398.352228,"marketCap":4913367253},{"date":"2024-09-27","current":-1641.015636,"twenty":-1479.542034,"median":-435.672004,"eighty":-401.33473,"marketCap":5405505506},{"date":"2024-10-04","current":-1582.129844,"twenty":-1582.616503,"median":-445.348351,"eighty":-408.313205,"marketCap":5211535706},{"date":"2024-10-11","current":-1384.546111,"twenty":-1557.991535,"median":-1361.673117,"eighty":-414.50986,"marketCap":4560694889},{"date":"2024-10-18","current":-1422.505547,"twenty":-1506.405635,"median":-1387.466067,"eighty":-417.984619,"marketCap":4685733272},{"date":"2024-10-25","current":-1513.510863,"twenty":-1501.052381,"median":-1410.582391,"eighty":-419.837824,"marketCap":4985504782},{"date":"2024-10-31","current":-1488.204572,"twenty":-1545.825049,"median":-1419.58559,"eighty":-422.588676,"marketCap":4902145859},{"date":"2024-11-08","current":-29.444986,"twenty":-1544.267739,"median":-1421.532228,"eighty":-422.588676,"marketCap":5359016876},{"date":"2024-11-15","current":-29.547337,"twenty":-1525.190689,"median":-1414.232336,"eighty":-406.749563,"marketCap":5377644907},{"date":"2024-11-22","current":-27.361909,"twenty":-1504.167001,"median":-1405.472467,"eighty":-395.977809,"marketCap":4979894851},{"date":"2024-11-29","current":-26.339693,"twenty":-1496.769778,"median":-1384.546111,"eighty":-392.705744,"marketCap":4793850470},{"date":"2024-12-06","current":-28.33551,"twenty":-1493.655158,"median":-903.058146,"eighty":-29.829328,"marketCap":5157091209},{"date":"2024-12-13","current":-28.454992,"twenty":-1490.248542,"median":-439.701867,"eighty":-28.749622,"marketCap":5178836972},{"date":"2024-12-20","current":-27.223413,"twenty":-1484.895288,"median":-431.521704,"eighty":-28.258307,"marketCap":4954688343},{"date":"2024-12-27","current":-27.048786,"twenty":-1479.834029,"median":-428.191726,"eighty":-28.004145,"marketCap":4922906075},{"date":"2025-01-03","current":-25.973452,"twenty":-1479.444702,"median":-426.381956,"eighty":-27.732022,"marketCap":4727194212},{"date":"2025-01-10","current":-24.227183,"twenty":-1479.444702,"median":-422.183287,"eighty":-27.252823,"marketCap":4409371530},{"date":"2025-01-17","current":-26.460569,"twenty":-1468.54353,"median":-415.668113,"eighty":-26.869269,"marketCap":4815850013},{"date":"2025-01-24","current":-27.894348,"twenty":-1465.818237,"median":-402.058638,"eighty":-26.861301,"marketCap":5076799163},{"date":"2025-01-31","current":-27.407231,"twenty":-1462.314289,"median":-396.991281,"eighty":-26.925021,"marketCap":4988143362},{"date":"2025-02-07","current":-27.09474,"twenty":-1459.102337,"median":-394.674774,"eighty":-26.925021,"marketCap":4931269830},{"date":"2025-02-14","current":-19.646244,"twenty":-1457.642359,"median":-390.041762,"eighty":-26.782239,"marketCap":4247537655},{"date":"2025-02-21","current":-19.437413,"twenty":-1455.695721,"median":-30.305187,"eighty":-26.72172,"marketCap":4202388031},{"date":"2025-02-28","current":-18.385222,"twenty":-1452.094441,"median":-29.520901,"eighty":-26.562732,"marketCap":3974903390},{"date":"2025-03-07","current":-18.486889,"twenty":-1446.059864,"median":-28.777108,"eighty":-26.339693,"marketCap":3996883783},{"date":"2025-03-14","current":-16.449855,"twenty":-1440.122619,"median":-28.454992,"eighty":-26.179328,"marketCap":3556475076},{"date":"2025-03-21","current":-17.921046,"twenty":-1437.981318,"median":-28.198548,"eighty":-25.317223,"marketCap":3874548031},{"date":"2025-03-28","current":-18.76981,"twenty":-1430.38943,"median":-27.986257,"eighty":-24.094834,"marketCap":4058051659},{"date":"2025-04-04","current":-16.296269,"twenty":-1422.116219,"median":-27.889753,"eighty":-20.198845,"marketCap":3523269657},{"date":"2025-04-11","current":-15.87621,"twenty":-1419.974918,"median":-27.820821,"eighty":-19.520945,"marketCap":3432452458},{"date":"2025-04-17","current":-15.802935,"twenty":-1417.346957,"median":-27.682957,"eighty":-19.180725,"marketCap":3416610370},{"date":"2025-04-25","current":-17.317281,"twenty":-1415.400319,"median":-27.425612,"eighty":-18.846182,"marketCap":3744013527},{"date":"2025-05-02","current":-17.960471,"twenty":-1411.604376,"median":-27.370467,"eighty":-18.532156,"marketCap":3883071858},{"date":"2025-05-09","current":-18.233962,"twenty":-1408.19776,"median":-27.329108,"eighty":-18.405555,"marketCap":4289685457},{"date":"2025-05-16","current":-21.240398,"twenty":-1401.871187,"median":-27.223413,"eighty":-18.515128,"marketCap":4996973579},{"date":"2025-05-23","current":-21.307828,"twenty":-1386.882076,"median":-27.071763,"eighty":-18.645114,"marketCap":5012836988},{"date":"2025-05-30","current":-20.970679,"twenty":-1384.546111,"median":-26.979854,"eighty":-18.713226,"marketCap":4933519947},{"date":"2025-06-06","current":-21.779837,"twenty":-1366.053052,"median":-26.837395,"eighty":-18.714534,"marketCap":5123880845},{"date":"2025-06-13","current":-21.083062,"twenty":-1357.293182,"median":-26.745487,"eighty":-18.76981,"marketCap":4959958960},{"date":"2025-06-20","current":-21.397734,"twenty":-630.517125,"median":-26.722672,"eighty":-18.799724,"marketCap":5033988198},{"date":"2025-06-27","current":-20.715944,"twenty":-446.043303,"median":-26.635196,"eighty":-18.835877,"marketCap":4873591516},{"date":"2025-07-03","current":-19.974216,"twenty":-441.960461,"median":-26.551186,"eighty":-18.852455,"marketCap":4699094026},{"date":"2025-07-11","current":-19.329886,"twenty":-438.862005,"median":-26.400131,"eighty":-18.891318,"marketCap":4547510347},{"date":"2025-07-18","current":-18.603142,"twenty":-435.145985,"median":-26.322706,"eighty":-18.792246,"marketCap":4376538059},{"date":"2025-07-25","current":-18.767971,"twenty":-431.217662,"median":-26.184843,"eighty":-18.769074,"marketCap":4415315279},{"date":"2025-07-29","current":-18.588158,"twenty":-430.001496,"median":-26.065361,"eighty":-18.752986,"marketCap":4373012857}],"updateTime":1753875973170}}}